Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Notified -
Globe Newswire18-02-2025, 18:00
Stifel Launches Agency Structured Products Group to Expand 16-02-2023, 21:01